Emodin-mediated protection from acute myocardial infarction via inhibition of inflammation and apoptosis in local ischemic myocardium

Life Sciences

Volumn 81, Issue 17-18, 2007, Pages 1332-1338

  Wu, Yanxia ^a   Tu, Xin ^b   Lin, Guosheng ^a   Xia, Hao ^a   Huang, Hao ^c   Wan, Jing ^d   Cheng, Zhide ^e   Liu, Mengyuan ^e   Chen, Gao ^e   Zhang, Haimou ^e   Fu, Jinrong ^a   Liu, Qian ^d   Liu, Dong xu ^e  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c The First Hospital of Wuhan   (China)

^d WUHAN UNIVERSITY   (China)

^e HUBEI UNIVERSITY   (China)

Author keywords

Apoptosis; Emodin; Inflammation; Myocardial infarction

Indexed keywords

CASPASE 3; EMODIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMODIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL INFARCTION; MYOCARDIUM; NF-KAPPA B; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 35348975068     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.08.040     Document Type: Article

References (31)

1. Abbate A., Bussani R., Amin M.S., Vetrovec G.W., and Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. International Journal of Biochemistry & Cell Biology 38 (2006) 1834-1840
2. Baeuerle P.A. IkB-NF-kB structures: at the interface of inflammation control. Cell 95 (1998) 729-731
3. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., Dobrina A., Rossiello R., Silvestri F., Baldi F., and Di Sciascio G. Apoptosis and post-infarction left ventricular remodeling. Journal of Molecular and Cellular Cardiology 34 (2002) 165-174
4. Bialik S., Geenen D.L., Sasson I.E., Cheng R., Horner J.W., Evans S.M., Lord E.M., Koch C.J., and Kitsis R.N. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. Journal of Clinical Investigation 100 (1997) 1363-1372
5. Chan T.C., Chang C.J., Koonchanok N.M., and Geahlen R.L. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Biochemical and Biophysical Research Communications 193 (1993) 1152-1158
6. Chen R.F., Shen Y.C., Huang H.S., Liao J.F., Ho L.K., Chou Y.C., Wang W.Y., and Chen C.F. Evaluation of the anti-inflammatory and cytotoxic effects of anthraquinones and anthracenes derivatives in human leucocytes. Journal of Pharmacy and Pharmacology 56 (2004) 915-919
7. Condorelli G., Roncarati R., Ross Jr. J., Pisani A., Stassi G., Todaro M., Trocha S., Drusco A., Gu Y., Russo M.A., Frati G., Jones S.P., Lefer D.J., Napoli C., and Croce C.M. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 9977-9982
8. Du Y., and Ko K.M. Effects of emodin treatment on mitochondrial ATP generation capacity and antioxidant components as well as susceptibility to ischemia-reperfusion injury in rat hearts: single versus multiple doses and gender difference. Life Sciences 77 (2005) 2770-2782
9. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovascular Research 53 (2002) 31-47
10. Hoffmeyer M.R., Scalia R., Ross C.R., Jones S.P., and Lefer D.J. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice. American Journal of Physiology, Heart and Circulatory Physiology 279 (2000) H2824-H2828
11. Koyama M., Kelly T.R., and Watanabe K.A. Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. Journal of Medicinal Chemistry 31 (1988) 283-284
12. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., Glembotski C.C., Quintana P.J., and Sabbadini R.A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. Journal of Clinical Investigation 98 (1996) 2854-2865
13. Kumar A., Dhawan S., and Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17 (1998) 913-918
14. Latini R., Bianchi M., Correale E., Dinarello C.A., Fantuzzi G., Fresco C., Maggioni A.P., Mengozzi M., Romano S., and Shapiro L. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. Journal of Cardiovascular Pharmacology 23 (1994) 1-6
15. Li H.L., Chen H.L., Li H., Zhang K.L., Chen X.Y., Wang X.W., Kong Q.Y., and Liu J. Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages. International Journal of Molecular Medicine 16 (2005) 41-47
16. Lu J.S., Liu J.X., Zhang W.Y., Liang S.W., Wang D., and Fang J. [Preventive effects of emodin on cerebral ischemia injury and expression of the inflammatory factors in rats with cerebral ischemia]. Zhongguo Zhongyao Zazhi 30 (2005) 1939-1943
17. Mallat Z., Tedgui A., Fontaliran F., Frank R., Durigon M., and Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. New England Journal of Medicine 335 (1996) 1190-1196
18. Narula J., Pandey P., Arbustini E., Haider N., Narula N., Kolodgie F.D., Dal Bello B., Semigran M.J., Bielsa-Masdeu A., Dec G.W., Israels S., Ballester M., Virmani R., Saxena S., and Kharbanda S. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 8144-8149
19. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 94 (2004) 1543-1553
20. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., and Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. American Journal of Physiology. Heart and Circulatory Physiology 280 (2001) H2726-H2731
21. Sam F., Sawyer D.B., Chang D.L., Eberli F.R., Ngoy S., Jain M., Amin J., Apstein C.S., and Colucci W.S. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) H422-H428
22. Shiomi T., Tsutsui H., Matsusaka H., Murakami K., Hayashidani S., Ikeuchi M., Wen J., Kubota T., Utsumi H., and Takeshita A. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109 (2004) 544-549
23. Su H.Y., Cherng S.H., Chen C.C., and Lee H. Emodin inhibits the mutagenicity and DNA adducts induced by 1-nitropyrene. Mutation Research 329 (1995) 205-212
24. Sun M., Dawood F., Wen W.H., Chen M., Dixon I., Kirshenbaum L.A., and Liu P.P. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110 (2004) 3221-3228
25. Syed F.M., Hahn H.S., Odley A., Guo Y., Vallejo J.G., Lynch R.A., Mann D.L., Bolli R., and Dorn II G.W. Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia. Circulation Research 96 (2005) 1103-1109
26. Tarnavski O., McMullen J.R., Schinke M., Nie Q., Kong S., and Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiological Genomics 16 (2004) 349-360
27. Torre-Amione G. Immune activation in chronic heart failure. American Journal of Cardiology 95 (2005) 3C-8C (discussion 38C-40C)
28. Torre-Amione G., Stetson S.J., Youker K.A., Durand J.B., Radovancevic B., Delgado R.M., Frazier O.H., Entman M.L., and Noon G.P. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100 (1999) 1189-1193
29. Valen G. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Research in Cardiology 99 (2004) 1-7
30. Zhou X.M., and Chen Q.H. Biochemical study of Chinese rhubarb. XXII. Inhibitory effect of anthraquinone derivatives on Na+-K+-ATPase of the rabbit renal medulla and their diuretic action. Yaoxue Xuebao 23 (1988) 17-20
31. Zhou Y.Y., Wang S.Q., Zhu W.Z., Chruscinski A., Kobilka B.K., Ziman B., Wang S., Lakatta E.G., Cheng H., and Xiao P.R. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. American Journal of Physiology, Heart and Circulatory Physiology 279 (2000) H429-H436